University of Hertfordshire

From the same journal

Urinary Biomarkers: Mitigating Diagnostic Delays of Bladder Cancer in the COVID-19 era
Research output: Contribution to journal › Article › peer-review

By the same authors

12 Minutes and the simple seven
Research output: Contribution to journal › Article › peer-review
Effects of a Brief E-Learning Resource on Sexual Attitudes and Beliefs of Healthcare Professionals Working in Prostate Cancer Care: A Pilot Study
Research output: Contribution to journal › Article › peer-review
Can simvastatin improve erectile function and health-related quality of life in men aged ≥40 years with erectile dysfunction? Results of the Erectile Dysfunction and Statins Trial [ISRCTN66772971]
Research output: Contribution to journal › Article › peer-review
Simvastatin improves the sexual health-related quality of life in men aged 40 years and over with erectile dysfunction: Additional data from the Erectile Dysfunction and Statin trial
Research output: Contribution to journal › Article › peer-review
Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies
Research output: Contribution to journal › Review article › peer-review

Is duloxetine safe and effective for the treatment of overactive bladder?

Research output: Contribution to journal › Article › peer-review

Michael Kirby
K.B. Thor

Original language	English
Pages (from-to)	188-189
Journal	Nature Reviews Urology
Volume	5
Issue	4
DOIs	https://doi.org/10.1038/ncpuro1077
Publication status	Published - 2008

Abstract

Overactive bladder (OAB) is frequently treated with antimuscarinic agents; however, the serotonin-noradrenaline reuptake inhibitor (SNRI) duloxetine has demonstrated efficacy in animal models of OAB, and might be effective in humans.

Notes

Original article can be found at: http://www.nature.com/ Copyright Nature Publishing Group [Full text of this article is not available in the UHRA]

ID: 408501